Skip to main content
SpringerLink
Log in

Cognitive Behavioral Therapy for Adherence and Depression in Diabetes

  • Chapter
  • First Online:
The Massachusetts General Hospital Handbook of Behavioral Medicine

Part of the book series: Current Clinical Psychiatry ((CCPSY))

  • 1263 Accesses

Abstract

Diabetes mellitus is a chronic health condition distinguished by a complex set of self-management behaviors needed to achieve blood glucose control in order to minimize risk of future complications. Diabetes is a highly prevalent disease with as many as 14 % of US adults are estimated to have diagnosed or undiagnosed diabetes. Those with diagnosed diabetes are at increased risk for certain psychological conditions, including depression, anxiety, and diabetes-related emotional distress. Importantly, subclinical symptoms of emotional distress have been linked to poorer self-management and poorer health outcomes among individuals treated for diabetes. An integrative approach that follows behavioral medicine principles is needed to improve emotional well-being and self-management outcomes. Research on cognitive behavioral therapy for adherence and depression (CBT-AD) has demonstrated benefits for improved glycemic control, diabetes self-management, adherence, and depression. The current chapter provides an overview of the diagnostic presentation of patients with diabetes, describes the CBT-AD approach developed within the Behavioral Medicine Service at Massachusetts General Hospital, and illustrates its application with a case example.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA. 2015;314:1021–9. doi:10.1001/jama.2015.10029.

    Article  CAS  PubMed  Google Scholar 

  2. Glasgow RE, Boles SM, McKay HG, et al. The D-Net diabetes self-management program: long-term implementation, outcomes, and generalization results. Prev Med. 2003;36:410–9. doi:10.1016/S0091-7435(02)00056-7.

    Article  PubMed  Google Scholar 

  3. Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364:1523–37.

    Article  PubMed  Google Scholar 

  4. U.S. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. US Dep Heal Hum Serv Centers Dis Control Prev. 2011;3:1–12.

    Google Scholar 

  5. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. Am J Cardiol. 1995;75:894–903. doi:10.1016/S0002-9149(99)80683-3.

    Article  Google Scholar 

  6. Stratton IM, Adler AI, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J. 2000;321:405–12.

    Article  CAS  Google Scholar 

  7. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care. 2015;38:S1–94.

    Google Scholar 

  8. Feldman BS, Cohen-Stavi CJ, Leibowitz M, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS One. 2014;9:e108145.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Hood KK, Peterson CM, Rohan JM, Drotar D. Association between adherence and glycemic control in pediatric type 1 diabetes: a meta-analysis. Pediatrics. 2009;124:e1171–9. doi:10.1542/peds.2009-0207.

    Article  PubMed  Google Scholar 

  10. Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;166:1836–41. doi:10.1001/archinte.166.17.1836.

    Article  PubMed  Google Scholar 

  11. DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 Years of research. Med Care. 2004;42:200–9. doi:10.1097/01.mlr.0000114908.90348.f9.

    Article  PubMed  Google Scholar 

  12. Nicolucci A, Kovacs Burns K, Holt RIG, et al. Diabetes attitudes, wishes and needs second study (DAWN2TM): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30:767–77. doi:10.1111/dme.12245.

    Article  CAS  PubMed  Google Scholar 

  13. Russell LB, Dong-Churl S, Safford MA. Time requirements for diabetes self-management: too much for many? J Fam Pract. 2005;54:52–6.

    PubMed  Google Scholar 

  14. Casagrande SS, Fradkin JE, Saydah SH, et al. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36:2271–9. doi:10.2337/dc12-2258.

    Article  CAS  Google Scholar 

  15. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 2001;24:1069–78. doi:10.2337/diacare.24.6.1069.

    Article  CAS  PubMed  Google Scholar 

  16. Ali S, Stone MA, Peters JL, et al. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006;23:1165–73. doi:10.1111/j.1464-5491.2006.01943.x.

    Article  CAS  PubMed  Google Scholar 

  17. Roy T, Lloyd CE, Pouwer F, et al. Screening tools used for measuring depression among people with Type 1 and Type 2 diabetes: a systematic review. Diabet Med. 2012;29:164–75. doi:10.1111/j.1464-5491.2011.03401.x.

    Article  CAS  PubMed  Google Scholar 

  18. Fisher L, Skaff MM, Mullan JT, et al. Clinical depression versus distress among patients with type 2 diabetes. Diabetes Care. 2007;30:542–8. doi:10.2337/dc06-1614.

    Article  PubMed  Google Scholar 

  19. Gonzalez JS, Safren SA, Cagliero E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007;30:2222–7. doi:10.2337/dc07-0158.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Li C, Barker L, Ford ES, et al. Diabetes and anxiety in US adults: findings from the 2006 behavioral risk factor surveillance system. Diabet Med. 2008;25:878–81. doi:10.1111/j.1464-5491.2008.02477.x.

    Article  CAS  PubMed  Google Scholar 

  21. Fisher L, Skaff MM, Mullan JT, et al. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008;25:1096–101. doi:10.1111/j.1464-5491.2008.02533.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Lin EHB, Von Korff M, Alonso J, et al. Mental disorders among persons with diabetes—results from the World Mental Health Surveys. J Psychosom Res. 2008;65:571–80. doi:10.1016/j.jpsychores.2008.06.007.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jones JM, Lawson ML, Daneman D, et al. Eating disorders in adolescent females with and without type 1 diabetes: cross sectional study. BMJ. 2000;320:1563–6. doi:10.1136/bmj.320.7249.1563.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Papelbaum M, Appolinário J, Moreira R, et al. Prevalence of eating disorders and psychiatric comorbidity in a clinical sample of type 2 diabetes mellitus patients. Rev Bras Psiquiatr. 2005;27:135–8.

    Article  PubMed  Google Scholar 

  25. Hudson J, Hiripi E, Pope HJ, Kessler R. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry. 2007;61:348–58. doi:10.1016/j.biopsych.2006.03.040.

    Article  PubMed  Google Scholar 

  26. Herpertz S, Albus C, Wagener R, et al. Comorbidity of diabetes and eating disorders: does diabetes control reflect disturbed eating behavior? Diabetes Care. 1998;21:1110–6. doi:10.2337/diacare.21.7.1110.

    Article  CAS  PubMed  Google Scholar 

  27. Crow S, Kendall D, Praus B, Thuras P. Binge eating and other psychopathology in patients with type II diabetes mellitus. Int J Eat Disord. 2001;30:222–6.

    Article  CAS  PubMed  Google Scholar 

  28. Mannucci E, Tesi F, Ricca V, et al. Eating behavior in obese patients with and without type 2 diabetes mellitus. Int J Obes Relat Metab Disord. 2002;26:848–53. doi:10.1038/sj.ijo.0801976.

    Article  CAS  PubMed  Google Scholar 

  29. Carroll P, Tiggemann M, Wade T. The role of body dissatisfaction and bingeing in the self-esteem of women with type II diabetes. J Behav Med. 1999;22:59–74. doi:10.1023/A:1018799618864.

    Article  CAS  PubMed  Google Scholar 

  30. Allison K, Crow S, Reeves R, et al. Binge eating disorder and night eating syndrome in adults with type 2 diabetes. Obesity (Silver Spring). 2007;15:1287–93.

    Article  PubMed Central  Google Scholar 

  31. Goodwin RD, Hoven CW, Spitzer RL. Diabetes and eating disorders in primary care. Int J Eat Disord. 2003;33:85–91.

    Article  PubMed  Google Scholar 

  32. Rouillon F, Sorbara F. Schizophrenia and diabetes: epidemiological data. Eur Psychiatry. 2005;20 Suppl 4:S345–8. doi:10.1016/S0924-9338(05)80189-0.

    Article  PubMed  Google Scholar 

  33. Schoepf D, Potluri R, Uppal H, et al. Type-2 diabetes mellitus in schizophrenia: Increased prevalence and major risk factor of excess mortality in a naturalistic 7-year follow-up. Eur Psychiatry. 2012;27:33–42. doi:10.1016/j.eurpsy.2011.02.009.

    Article  CAS  PubMed  Google Scholar 

  34. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368–73. doi:10.1111/j.1399-5618.2004.00138.x.

    Article  PubMed  Google Scholar 

  35. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28:626–31.

    Article  PubMed  Google Scholar 

  36. Deschês SS, Burns RJ, Schmitz N. Associations between diabetes, major depressive disorder and generalized anxiety disorder comorbidity, and disability: findings from the 2012 Canadian Community Health Survey-Mental Health (CCHS-MH). J Psychosom Res. 2015;78:137–42.

    Article  Google Scholar 

  37. Mollema ED, Snoek FJ, Heine RJ, Van Der Ploeg HM. Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med. 2001;18:671–4. doi:10.1046/j.1464-5491.2001.00547.x.

    Article  CAS  PubMed  Google Scholar 

  38. Weinger K, Lee J. Psychosocial and psychiatric challenges of diabetes mellitus. Nurs Clin North Am. 2006;41:667–80. doi:10.1016/j.cnur.2006.07.002.

    Article  PubMed  Google Scholar 

  39. Gonzalez JS, Esbitt SA, Schneider HE, et al. Psychological issues in adults with type 2 diabetes. Psychological co-morbidities of physical illness. New York: Springer; 2011. p. 73–121.

    Book  Google Scholar 

  40. Gonzalez JS, Hood KK, Esbitt SA, et al. Psychiatric and psychosocial issues among individuals living with diabetes. Diabetes in America. 2nd ed. NIDDK; in press.

    Google Scholar 

  41. Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398–403. doi:10.2337/dc08-1341.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35:2472–8. doi:10.2337/dc12-0181.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865–71.

    Article  PubMed  Google Scholar 

  44. Zanoveli JM, de Morais H, de Silva Dias IC, et al. Depression associated with diabetes: from pathophysiology to treatment. Curr Diabetes Rev. 2015;11:1–11.

    Article  Google Scholar 

  45. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73:114–26.

    Article  PubMed  Google Scholar 

  46. Leventhal H, Leventhal EA, Contrada RJ. Self-regulation, health, and behavior: a perceptual-cognitive approach. Psychol Health. 1998;13:717–33. doi:10.1080/08870449808407425.

    Article  Google Scholar 

  47. Horne R, Chapman SCE, Parham R, et al. Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework. PLoS One. 2013;8(12):e80633. doi:10.1371/journal.pone.0080633.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  48. Mc Sharry J, Moss-Morris R, Kendrick T. Illness perceptions and glycaemic control in diabetes: a systematic review with meta-analysis. Diabet Med. 2011;28:1300–10. doi:10.1111/j.1464-5491.2011.03298.x.

    Article  CAS  PubMed  Google Scholar 

  49. Brown AF, Ettner SL, Piette J, et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev. 2004;26:63–77. doi:10.1093/epirev/mxh002.

    Article  PubMed  Google Scholar 

  50. Sclar DA, Robison LM, Skaer TL, Galin RS. Trends in the prescribing of antidepressant pharmacotherapy: office-based visits, 1990–1995. Clin Ther. 1998;20:871–84. doi:10.1016/S0149-2918(98)80148-3.

    Article  CAS  PubMed  Google Scholar 

  51. MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ. 2003;326:1014. doi:10.1136/bmj.326.7397.1014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Goodnick PJ, Henry JH, Buki VM. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry. 1995;56:128–36.

    CAS  PubMed  Google Scholar 

  53. Ye Z, Chen L, Yang Z, et al. Metabolic effects of fluoxetine in adults with type 2 diabetes mellitus: a meta-analysis of randomized placebo-controlled trials. PLoS One. 2011;6(7):e21551. doi:10.1371/journal.pone.0021551.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Thase ME, Haight BR, Richard N, et al. Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry. 2005;66:974–81.

    Article  CAS  PubMed  Google Scholar 

  55. Lustman PJ, Williams MM, Sayuk GS, Nix BD, Clouse RE. Factors influencing glycemic control in type 2 diabetes during acute-and maintenance-phase treatment of major depressive disorder with bupropion. Diabetes Care. 2007;30(3):459–66.

    Google Scholar 

  56. Goodnick P. Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy. Ann Clin Psychiatry. 2001;13:31–4.

    Article  CAS  PubMed  Google Scholar 

  57. Philip NS, Carpenter LL, Tyrka AR, Price LH. Augmentation of antidepressants with atypical antipsychotics: a review of the current literature. J Psychiatr Pract. 2008;14:34–44. doi:10.1097/01.pra.0000308493.93003.92.

    Article  PubMed  Google Scholar 

  58. Lett TAP, Wallace TJM, Chowdhury NI, et al. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol Psychiatry. 2012;17:242–66. doi:10.1038/mp.2011.109.

    Article  CAS  PubMed  Google Scholar 

  59. Haddad PM, Sharma SG. Adverse effects of atypical antipsychotics: differential risk and clinical implications. CNS Drugs. 2007;21:911–36. doi: 21114 [pii].

    Article  CAS  PubMed  Google Scholar 

  60. Markowitz SM, Gonzalez JS, Wilkinson JL, Safren SA. A review of treating depression in diabetes: emerging findings. Psychosomatics. 2011;52:1–18. doi:10.1016/j.psym.2010.11.007.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care. 2001;24:561–87. doi:10.2337/diacare.24.3.561.

    Article  CAS  PubMed  Google Scholar 

  62. Fisher L, Hessler D, Glasgow RE, et al. REDEEM: a pragmatic trial to reduce diabetes distress. Diabetes Care. 2013;36:2551–8. doi:10.2337/dc12-2493.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Bell AC, D’Zurilla TJ. Problem-solving therapy for depression: a meta-analysis. Clin Psychol Rev. 2009;29:348–53. doi:10.1016/j.cpr.2009.02.003.

    Article  PubMed  Google Scholar 

  64. Hill-Briggs F, Gemmell L. Problem solving in diabetes self-management and control: a systematic review of the literature. Diabetes Educ. 2007;33:1032–50. doi:10.1177/0145721707308412; discussion 1051–2.

    Article  PubMed  Google Scholar 

  65. Fitzpatrick SL, Schumann KP, Hill-Briggs F. Problem solving interventions for diabetes self-management and control: a systematic review of the literature. Diabetes Res Clin Pract. 2013;100:145–61. doi:10.1016/j.diabres.2012.12.016.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Safren SA, Gonzalez JS, Soroudi N. Coping with chronic illness, therapist guide. New York: Oxford University Press; 2007.

    Book  Google Scholar 

  67. Safren SA, Gonzalez JS, Wexler DJ, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in patients with uncontrolled type 2 diabetes. Diabetes Care. 2014;37:625–33. doi:10.2337/dc13-0816.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Markowitz SM, Carper MM, Gonzalez JS, Delahanty LM, Safren SA. Cognitive-behavioral therapy for the treatment of depression and adherence in patients with type 1 diabetes: pilot data and feasibility. Prim Care Companion CNS Disord. 2012;14(2).

    Google Scholar 

  69. Esbitt SA, Batchelder AW, Tanenbaum ML, et al. “Knowing That You’re Not the Only One”: perspectives on group-based cognitive-behavioral therapy for adherence and depression (CBT-AD) in adults with type 1 diabetes. Cogn Behav Pract. 2014;22(3):393–406. doi:10.1016/j.cbpra.2014.02.006.

    Article  PubMed Central  Google Scholar 

  70. Soroudi N, Perez GK, Gonzalez JS, et al. CBT for Medication Adherence and Depression (CBT-AD) in HIV-infected patients receiving methadone maintenance therapy. Cogn Behav Pract. 2008;15:93–106. doi:10.1016/j.cbpra.2006.11.004.

    Article  Google Scholar 

  71. Safren SA, O’Cleirigh C, Tan JY, et al. A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol. 2009;28:1–10. doi:10.1037/a0012715.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Gonzalez JS, McCarl LA, Wexler DJ, et al. Cognitive–behavioral therapy for adherence and depression (CBT-AD) in type 2 diabetes. J Cogn Psychother. 2010;24:329–43. doi:10.1891/0889-8391.24.4.329.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Safren SA, O’Cleirigh CM, Bullis JR, et al. Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol. 2012;80:404–15. doi:10.1037/a0028208.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Simoni JM, Wiebe JS, Sauceda JA, et al. A preliminary RCT of CBT-AD for adherence and depression among HIV-positive latinos on the U.S.-Mexico border: the Nuevo Dia study. AIDS Behav. 2013;17:2816–29. doi:10.1007/s10461-013-0538-5.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Berg C, Raminani S, Greer J, et al. Participants’ perspectives on cognitive-behavioral therapy for adherence and depression in HIV. Psychother Res. 2008;18:271–80. doi:10.1080/10503300701561537.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Safren SA, Gonzalez JS, Soroudi N. Coping with chronic illness, workbook. New York: Oxford University Press; 2007.

    Book  Google Scholar 

  77. Miller W, Rollnick S. Motivational interviewing, helping people change. 3rd ed. New York: Guilford; 2013.

    Google Scholar 

  78. Harvey JN. Psychosocial interventions for the diabetic patient. Diabetes Metab Syndr Obes. 2015;8:29–43.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39:1151–62. doi:10.1016/S0005-7967(00)00091-7.

    Article  CAS  PubMed  Google Scholar 

  80. Linehan M. Skills training manual for treating borderline personality disorder. New York: Guilford; 1993.

    Google Scholar 

  81. Beck AT. Cognitive therapy of depression. New York: Guilford; 1979.

    Google Scholar 

  82. Beck JS. Cognitive behavior therapy: basics and beyond. 2nd ed. New York: Guilford; 2011.

    Google Scholar 

  83. D’Zurilla TJ. Problem-solving therapy: a positive approach to clinical intervention. 3rd ed. New York: Springer; 2007.

    Google Scholar 

  84. Cotanch P. Relaxation training for control of nausea and vomiting in patients receiving chemotherapy. Cancer Nurs. 1983;6:277–83.

    Article  CAS  PubMed  Google Scholar 

  85. Turner J, Chapman C. Psychological intervention for chronic pain: a critical review-relaxation and biofeedback. Pain. 1982;12:1–221.

    Article  CAS  PubMed  Google Scholar 

  86. Smith W. Biofeedback and relaxation training: the effect on headache and associated symptoms. Headache. 1987;27:511–4.

    Article  CAS  PubMed  Google Scholar 

  87. Ost L. Applied Relaxation: manual for a behavioral coping technique. Department of Psychology, Stockholm University.

    Google Scholar 

  88. Otto M, Jones J, Craske M, Barlow D. Stopping anxiety medication: panic control therapy for benzodiazepine discontinuation (therapist guide). San Antonio: Psychological Corporation; 1996.

    Google Scholar 

  89. Tanenbaum ML, Ritholz MD, Binko DH, et al. Probing for depression and finding diabetes: a mixed-methods analysis of depression interviews with adults treated for type 2 diabetes. J Affect Disord. 2013;150:533–9. doi:10.1016/j.jad.2013.01.029.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Tanenbaum ML, Gonzalez JS. The influence of diabetes on a clinician-rated assessment of depression in adults with type 1 diabetes. Diabetes Educ. 2012;38:695–704. doi:10.1177/0145721712452795.

    Article  PubMed  Google Scholar 

  91. Fisher L, Glasgow RE, Mullan JT, et al. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008;6:246–52. doi:10.1370/afm.842.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Fisher L, Hessler D, Polonsky WH, Mullan J. When is diabetes distress meaningful? Establishing cut points for the diabetes distress scale. Diabetes Care. 2012;35:259–64.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Weinger K, Butler HA, Welch GW, La Greca AM. Measuring diabetes self-care: a psychometric analysis of the Self-Care Inventory-Revised with adults. Diabetes Care. 2005;28:1346–52.

    Article  PubMed  PubMed Central  Google Scholar 

  94. La Greca A. Manual for the self care inventory. Miami: University of Miami; 2004.

    Google Scholar 

  95. Khagram L, Martin CR, Davies MJ, Speight J. Psychometric validation of the Self-Care Inventory-Revised (SCI-R) in UK adults with type 2 diabetes using data from the AT.LANTUS follow-on study. Health Qual Life Outcomes. 2013;11:24. doi:10.1186/1477-7525-11-24.

    Article  PubMed  PubMed Central  Google Scholar 

  96. Gonzalez JS, Schneider HE. Methodological issues in the assessment of diabetes treatment adherence. Curr Diab Rep. 2011;11(6):472–9.

    Google Scholar 

  97. Gonzalez JS, Schneider HE, Wexler DJ, et al. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013;36:831–7. doi:10.2337/dc12-0410.

    Article  PubMed  PubMed Central  Google Scholar 

  98. Chomutare T, Fernandez-Luque L, Arsand E, Hartvigsen G. Features of mobile diabetes applications: review of the literature and analysis of current applications compared against evidence-based guidelines. J Med Internet Res. 2011;13(3):e65. doi:10.2196/jmir.1874.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Wilson IB, Fowler Jr FJ, Cosenza CA, Michaud J, Bentkover J, Rana A, Kogelman L, Rogers WH. Cognitive and field testing of a new set of medication adherence self-report items for HIV care. AIDS Behav. 2014;18(12):2349–58.

    Google Scholar 

  100. United Kingdom Prospective Diabetes Study (UKPDS) Group. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ. 1995;310:83–8. doi:10.1136/bmj.310.6972.83.

    Article  Google Scholar 

  101. Hermanns N, Schmitt A, Gahr A, et al. The effect of a diabetes-specific cognitive behavioral treatment program (DIAMOS) for patients with diabetes and subclinical depression: results of a randomized controlled trial. Diabetes Care. 2015;38(4):551–60. doi:10.2337/dc14-1416.

    CAS  PubMed  Google Scholar 

  102. Chen S, Creedy D, Lin H, Wollin J. Effects of motivational interviewing intervention on self-management, psychological and glycemic outcomes in type 2 diabetes: a randomized controlled trial. Int J Nurs Stud. 2012;49:637–44.

    Article  PubMed  Google Scholar 

  103. Gabbay RRA, Añel-Tiangco R, Dellasega C, et al. Diabetes nurse case management and motivational interviewing for change (DYNAMIC) results of a 2-year randomized control pragmatic trial. J Diabetes. 2013;5:349–57.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Welschen L, van Oppen P, Dekker J, et al. Effects of a cognitive behavioural treatment in patients with type 2 diabetes when added to managed care; a randomised controlled trial. BMC Public Health. 2007;7:74.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Huffman JC, DuBois CM, Millstein RA, et al. Positive psychological interventions for patients with type 2 diabetes: rationale, theoretical model, and intervention development. J Diabetes Res. 2015;2015:428349. doi:10.1155/2015/428349.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision. Diabet Med. 2014;31:764–72. doi:10.1111/dme.12428.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Montgomery SA, Asberg MA. A new depression scale designed to be sensitive to change. The British journal of psychiatry. 1979 Apr 1;134(4):382–9.

    Google Scholar 

Additional Resources

Download references

Author information

Authors and Affiliations

  1. Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, 10461, USA

    Jeffrey S. Gonzalez Ph.D. & Naomi S. Kane M.A.

  2. Diabetes Research Center, Albert Einstein College of Medicine, Yeshiva University, Bronx, NY, 10461, USA

    Jeffrey S. Gonzalez Ph.D.

  3. Depression Clinical and Research Program, Department of Psychiatry, Massachusetts General Hospital, 1 Bowdoin Square, 6th floor, Boston, MA, 02114, USA

    Trina E. Chang M.D., M.P.H.

Authors
  1. Jeffrey S. Gonzalez Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naomi S. Kane M.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Trina E. Chang M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey S. Gonzalez Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Psychiatry Behavioral Medicine Service, Massachusetts General Hospital, Boston, Massachusetts, USA

    Ana-Maria Vranceanu

  2. Dept. of Psychiatric Oncology & Behavior, Massachusetts General Hospital Cancer Ce, Boston, Massachusetts, USA

    Joseph A. Greer

  3. Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA

    Steven A. Safren

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Science+Business Media New York

About this chapter

Cite this chapter

Gonzalez, J.S., Kane, N.S., Chang, T.E. (2017). Cognitive Behavioral Therapy for Adherence and Depression in Diabetes. In: Vranceanu, AM., Greer, J., Safren, S. (eds) The Massachusetts General Hospital Handbook of Behavioral Medicine. Current Clinical Psychiatry. Humana Press, Cham. https://doi.org/10.1007/978-3-319-29294-6_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-29294-6_6

  • Published:

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-29292-2

  • Online ISBN: 978-3-319-29294-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation